The singer Preta Gil 50, started his 4th cycle of chemotherapy . On her social networks, the artist reported suffering from anticipatory nausea .
To her followers, the singer mentioned that her doctor had already spoken about the sensation, but until then, she had never felt the condition during treatment.
Through a video, Preta said that before she only felt sick when the chemotherapy medication had already entered her body. However, this Monday (7), she reported that she arrived at the hospital feeling sick.
“My penny dropped, I have anticipatory nausea, this really exists, I arrived here feeling sick. Our heads control everything”, he said.
According to a study by the Brazilian Society of Clinical Oncologyanxiety reported by the patient before starting treatment can trigger nausea and vomiting.
Also according to the study, patients who expect to feel nauseated before chemotherapy develop, in greater numbers, anticipatory nausea, differently from those who did not have the same expectation.
Preta Gil and the return of cancer treatment
In August, the voice of “Signs of Fire” shared a video sharing information about the return of cancer with his followers.
In the publication, she said that the disease had spread to four different places on her body. “Not only in my case, but in the case of 40% of people who have primary cancer and that’s what happened to me, my cancer came back”, he said.
“I have two lymph nodes, I have a metastasis that is in the peritoneum and I have a nodule, a lesion in the ureter”. The singer went to the hospital to do her routine exams, when she was surprised by the diagnosis.
Preta Gil prepares to launch documentary and book: “I’m happy”
This content was originally published in Preta Gil begins 4th cycle of chemotherapy and talks about anticipatory nausea on the CNN Brasil website.
Source: CNN Brasil
I’m Robert Neff, a professional writer and editor. I specialize in the entertainment section, providing up-to-date coverage on the latest developments in film, television and music. My work has been featured on World Stock Market and other prominent publications.
